We are live on ! Find out more
LSTA icon

Lisata Therapeutics
LSTA

50 hedge funds and large institutions have $13.6M invested in Lisata Therapeutics in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 11

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

0% more funds holding

Funds holding: 50 → 50 (0)

24% less capital invested

Capital invested by funds: $17.8M → $13.6M (-$4.19M)

87% less call options, than puts

Call options by funds: $103K | Put options by funds: $770K

Holders
50
Holders Change
–
Holders Change %
0%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
16
Reduced
11
Closed
12
Calls
$103K
Puts
$770K
Net Calls
-$667K
Net Calls Change
-$233K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$474K
2
Group One Trading
Group One Trading
Illinois
+$410K
3
BFA
BlackRock Fund Advisors
California
+$404K
4
Millennium Management
Millennium Management
New York
+$382K
5
SIP
Stoneridge Investment Partners
Pennsylvania
+$370K

Top Sellers

Rank Fund Capital Flow
1
TFO
Tarbox Family Office
California
-$535K
2
US Bancorp
US Bancorp
Minnesota
-$277K
3
Goldman Sachs
Goldman Sachs
New York
-$259K
4
AQR Capital Management
AQR Capital Management
Connecticut
-$215K
5
RCM
Rotella Capital Management
Washington
-$62K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.14M +$474K +696 +14%
BFA
2
BlackRock Fund Advisors
California
$2.44M +$404K +594 +16%
Northern Trust
3
Northern Trust
Illinois
$947K +$18.4K +27 +2%
State Street
4
State Street
Massachusetts
$910K +$60.6K +89 +6%
BIT
5
BlackRock Institutional Trust
California
$762K -$25.2K -37 -3%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$548K -$6.81K -10 -1%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$467K +$1.36K +2 +0.2%
Group One Trading
8
Group One Trading
Illinois
$419K +$410K +602 +433%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$378K +$259K +381 +132%
TCIM
10
TIAA CREF Investment Management
New York
$350K -$22.5K -33 -5%
Millennium Management
11
Millennium Management
New York
$317K +$382K +561 New
SIP
12
Stoneridge Investment Partners
Pennsylvania
$307K +$370K +543 New
BIM
13
BlackRock Investment Management
Delaware
$278K -$681 -1 -0.2%
RJA
14
Raymond James & Associates
Florida
$250K +$2.72K +4 +0.9%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$239K – – –
CS
16
Credit Suisse
Switzerland
$180K +$216K +318 New
California State Teachers Retirement System (CalSTRS)
17
California State Teachers Retirement System (CalSTRS)
California
$165K +$681 +1 +0.3%
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$154K – – –
Morgan Stanley
19
Morgan Stanley
New York
$148K +$34K +50 +24%
Charles Schwab
20
Charles Schwab
California
$131K – – –
Citadel Advisors
21
Citadel Advisors
Florida
$128K +$117K +172 +313%
TA
22
Teachers Advisors
New York
$124K – – –
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$106K +$33.4K +49 +36%
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$97K +$7.49K +11 +7%
NFA
25
Nationwide Fund Advisors
Ohio
$68K – – –
1
2 3

LSTA Hedge Fund Activity: Q4 2014 in Review

50 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q4 2014, worth a combined $13.6M — down 24% from $17.8M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LSTA positions and 12 closed out — a net gain of 1 holder — while 16 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $474K. The largest seller was Tarbox Family Office, exiting entirely with an estimated $535K sold.

  • 50 institutional investors held Lisata Therapeutics (LSTA) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $13.6M of Lisata Therapeutics stock for Q4 2014, down 24% quarter-over-quarter.
  • 13 funds opened new Lisata Therapeutics positions in Q4 2014 and 12 closed out, a net change of +1 holder.
  • The largest Lisata Therapeutics buyer in Q4 2014 was Vanguard Group, an estimated $474K added.
  • The largest Lisata Therapeutics seller in Q4 2014 was Tarbox Family Office, an estimated $535K sold.

Based on aggregated 13F filings for Q4 2014.